AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Oncopeptides, Inc. Data, Technology Stack, and Enterprise Applications
Analytics and BI
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Veeva Systems Legacy Veeva Oncology Link Analytics and BI Analytics and BI n/a 2020 2020
In 2020, Oncopeptides, Inc. implemented Veeva Oncology Link to centralize oncology-specific intelligence for its commercial organization. Veeva Oncology Link is used as an Analytics and BI application to deliver curated intelligence on people, institutions, and developments across the oncology healthcare community, supporting field engagement and strategic sales analytics. The deployment consolidated clinician and institutional profiles, research and clinical development signals, and outreach intelligence into a single access layer for field teams and the sales analytics function. Configuration emphasized data access and role-based delivery for field users, with sales analytics responsible for operational oversight and content curation. Oncopeptides, Inc. Veeva Oncology Link Analytics and BI relationships focus on enabling field engagement workflows and supporting sales analytics reporting, with users reporting that the solution provides intelligence on people, institutions, and developments all in one place.
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2018 2018
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Oracle Legacy Oracle Moat Marketing Analytics CRM n/a 2021 2021
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2018 2018
Content Delivery Network IaaS 2021 2021
IT Decision Makers and Key Stakeholders at Oncopeptides, Inc.
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Oncopeptides, Inc. Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Oncopeptides, Inc. Technographics

Oncopeptides, Inc. is a Life Sciences organization based in United States, with around 88 employees and annual revenues of $7.0 million.

Oncopeptides, Inc. operates a diverse technology stack with applications such as Veeva Oncology Link, Microsoft 365 and Oracle Moat, covering areas like Analytics and BI, Collaboration and Marketing Analytics.

Oncopeptides, Inc. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Veeva Systems, Microsoft and Oracle.

Oncopeptides, Inc. recently adopted applications including Oracle Moat in 2021, Cloudflare CDN in 2021 and Veeva Oncology Link in 2020, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Oncopeptides, Inc.’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Oncopeptides, Inc.’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Oncopeptides, Inc. technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.